Page last updated: 2024-09-04

(3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid and Disease Models, Animal

(3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cryan, JF; Froestl, W; Kaupmann, K; Mombereau, C; Sansig, G; van der Putten, H1

Other Studies

1 other study(ies) available for (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid and Disease Models, Animal

ArticleYear
Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:6

    Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Benzoates; Cyclopentanes; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; GABA-B Receptor Antagonists; Hindlimb Suspension; Male; Maze Learning; Mice; Mice, Inbred BALB C; Mice, Knockout; Motor Activity; Phosphinic Acids; Psychomotor Performance; Pyrimidines; Reaction Time; Receptors, GABA-B; Swimming

2004